Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 129.38M
December 31, 2025 163.15M
September 30, 2025 155.79M
June 30, 2025 159.59M
March 31, 2025 132.08M
December 31, 2024 142.42M
September 30, 2024 141.91M
June 30, 2024 141.10M
March 31, 2024 157.05M
December 31, 2023 180.79M
September 30, 2023 156.84M
June 30, 2023 146.52M
March 31, 2023 151.90M
Date Value
December 31, 2022 112.98M
September 30, 2022 125.59M
June 30, 2022 125.47M
March 31, 2022 134.34M
December 31, 2021 146.27M
September 30, 2021 159.32M
June 30, 2021 176.28M
March 31, 2021 189.30M
December 31, 2020 203.29M
September 30, 2020 212.68M
June 30, 2020 77.07M
March 31, 2020
December 31, 2019 82.03M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Revolution Medicines, Inc. 753.82M
Erasca, Inc. 67.71M
Arrowhead Pharmaceuticals, Inc. 1.669B
Sarepta Therapeutics, Inc. 1.674B
Vir Biotechnology, Inc. 212.82M

Total Liabilities (Quarterly) Related Metrics